FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387117731> ?p ?o ?g. }

• W4387117731 abstract "The prognostic significance of number and location of organ-specific metastatic sites in treated metastatic clear cell renal carcinoma (ccmRCC) patients is object of debate. The current study aimed to test the association between number and location of organ-specific metastatic sites and overall survival (OS) in ccmRCC.Within Surveillance, Epidemiology and End Results database (2010-2018), all ccmRCC patients treated with cytoreductive nephrectomy and/or systemic therapy were identified. Kaplan-Meier plots and Cox regression models focused on: A). number of organ-specific metastatic sites: solitary vs. 2 vs. 3 or more; B). solitary organ-specific metastatic sites (lung vs. bone vs. liver vs. brain); C). combinations of 2 and 3 or more different organ-specific metastatic sites.Of 4,527 patients (median OS: 19 months), 3,054 (67%) harbored solitary organ-specific metastatic sites (27 months) vs. 1,153 (25%) combinations of 2 different organ-specific metastatic sites (12 months) vs. 320 (8%) combinations of 3 or more different organ-specific metastatic sites (7 months). In patients with solitary organ-specific metastatic sites, bone metastases portended the longest median OS (median OS: 31 months) vs. liver metastases portended the shortest median OS (16 months). Both were independent predictors of OS (multivariable hazard ratio, bone: 0.87; liver: 1.21). Median OS was similarly poor in patients with combinations of 2 different organ-specific metastatic sites (9-13 months), regardless of their location. The same pattern applied to patients with combinations of 3 or more different organ-specific metastatic sites (6-7 months).Solitary organ-specific metastatic sites portend the most favorable OS (16-31 months). Solitary bone metastases yield the longest vs. liver metastases the shortest OS. Invariably poor OS applies to combinations of 2 (9-13 months), as well as 3 or more different organ-specific metastatic sites (6-7 months), regardless of their location." @default.
• W4387117731 created "2023-09-29" @default.
• W4387117731 creator A5003968607 @default.
• W4387117731 creator A5009887316 @default.
• W4387117731 creator A5013463417 @default.
• W4387117731 creator A5014573705 @default.
• W4387117731 creator A5023354391 @default.
• W4387117731 creator A5025581341 @default.
• W4387117731 creator A5031548152 @default.
• W4387117731 creator A5031550729 @default.
• W4387117731 creator A5031699531 @default.
• W4387117731 creator A5032217427 @default.
• W4387117731 creator A5034195683 @default.
• W4387117731 creator A5037689340 @default.
• W4387117731 creator A5044228660 @default.
• W4387117731 creator A5047052351 @default.
• W4387117731 creator A5053749991 @default.
• W4387117731 creator A5054171484 @default.
• W4387117731 creator A5060661085 @default.
• W4387117731 creator A5060741928 @default.
• W4387117731 creator A5069425827 @default.
• W4387117731 creator A5069870311 @default.
• W4387117731 creator A5071652086 @default.
• W4387117731 creator A5079401169 @default.
• W4387117731 creator A5084398427 @default.
• W4387117731 creator A5091716475 @default.
• W4387117731 date "2023-09-01" @default.
• W4387117731 modified "2023-10-16" @default.
• W4387117731 title "Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites" @default.
• W4387117731 cites W1606733792 @default.
• W4387117731 cites W2057945830 @default.
• W4387117731 cites W2069701490 @default.
• W4387117731 cites W2099752220 @default.
• W4387117731 cites W2111378135 @default.
• W4387117731 cites W2137822543 @default.
• W4387117731 cites W2143782771 @default.
• W4387117731 cites W2147864956 @default.
• W4387117731 cites W2735496645 @default.
• W4387117731 cites W2747814067 @default.
• W4387117731 cites W2782289618 @default.
• W4387117731 cites W3026562924 @default.
• W4387117731 cites W3125140576 @default.
• W4387117731 cites W3131206243 @default.
• W4387117731 cites W4288056283 @default.
• W4387117731 cites W4293217252 @default.
• W4387117731 doi "https://doi.org/10.1016/j.urolonc.2023.08.014" @default.
• W4387117731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37775340" @default.
• W4387117731 hasPublicationYear "2023" @default.
• W4387117731 type Work @default.
• W4387117731 citedByCount "0" @default.
• W4387117731 crossrefType "journal-article" @default.
• W4387117731 hasAuthorship W4387117731A5003968607 @default.
• W4387117731 hasAuthorship W4387117731A5009887316 @default.
• W4387117731 hasAuthorship W4387117731A5013463417 @default.
• W4387117731 hasAuthorship W4387117731A5014573705 @default.
• W4387117731 hasAuthorship W4387117731A5023354391 @default.
• W4387117731 hasAuthorship W4387117731A5025581341 @default.
• W4387117731 hasAuthorship W4387117731A5031548152 @default.
• W4387117731 hasAuthorship W4387117731A5031550729 @default.
• W4387117731 hasAuthorship W4387117731A5031699531 @default.
• W4387117731 hasAuthorship W4387117731A5032217427 @default.
• W4387117731 hasAuthorship W4387117731A5034195683 @default.
• W4387117731 hasAuthorship W4387117731A5037689340 @default.
• W4387117731 hasAuthorship W4387117731A5044228660 @default.
• W4387117731 hasAuthorship W4387117731A5047052351 @default.
• W4387117731 hasAuthorship W4387117731A5053749991 @default.
• W4387117731 hasAuthorship W4387117731A5054171484 @default.
• W4387117731 hasAuthorship W4387117731A5060661085 @default.
• W4387117731 hasAuthorship W4387117731A5060741928 @default.
• W4387117731 hasAuthorship W4387117731A5069425827 @default.
• W4387117731 hasAuthorship W4387117731A5069870311 @default.
• W4387117731 hasAuthorship W4387117731A5071652086 @default.
• W4387117731 hasAuthorship W4387117731A5079401169 @default.
• W4387117731 hasAuthorship W4387117731A5084398427 @default.
• W4387117731 hasAuthorship W4387117731A5091716475 @default.
• W4387117731 hasConcept C126322002 @default.
• W4387117731 hasConcept C142724271 @default.
• W4387117731 hasConcept C143998085 @default.
• W4387117731 hasConcept C207103383 @default.
• W4387117731 hasConcept C2777472916 @default.
• W4387117731 hasConcept C2777546739 @default.
• W4387117731 hasConcept C2777714996 @default.
• W4387117731 hasConcept C2779975986 @default.
• W4387117731 hasConcept C2780091579 @default.
• W4387117731 hasConcept C44249647 @default.
• W4387117731 hasConcept C50382708 @default.
• W4387117731 hasConcept C71924100 @default.
• W4387117731 hasConceptScore W4387117731C126322002 @default.
• W4387117731 hasConceptScore W4387117731C142724271 @default.
• W4387117731 hasConceptScore W4387117731C143998085 @default.
• W4387117731 hasConceptScore W4387117731C207103383 @default.
• W4387117731 hasConceptScore W4387117731C2777472916 @default.
• W4387117731 hasConceptScore W4387117731C2777546739 @default.
• W4387117731 hasConceptScore W4387117731C2777714996 @default.
• W4387117731 hasConceptScore W4387117731C2779975986 @default.
• W4387117731 hasConceptScore W4387117731C2780091579 @default.
• W4387117731 hasConceptScore W4387117731C44249647 @default.
• W4387117731 hasConceptScore W4387117731C50382708 @default.
• W4387117731 hasConceptScore W4387117731C71924100 @default.
• W4387117731 hasLocation W43871177311 @default.

• next